|
|
Article: MDS appointed Gregory Spivy, a partner at ValueAct Capital (which holds 19% of the company's outstanding shares), and William Dempsey, former executive vice president of Abbott Laboratories.(Broad-Based Companies: Company Announcements)
- Article from:
- Instrument Business Outlook
- Article date:
- June 30, 2008
CopyrightCOPYRIGHT 2008 Strategic Directions International Inc. (SDI). This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
MDS appointed Gregory Spivy, a partner at ValueAct Capital (which holds 19% of the company's outstanding ...
Related newspaper, magazine, and journal articles:
|
|
Article: ValueAct Capital Notifies Acxiom of Its Intent to ...
Business Wire;
April 3, 2006 ;
700+ words
...SAN FRANCISCO -- ValueAct Capital today announced that it has ... Andreozzi and J. Michael Lawrie. ValueAct Capital is Acxiom's largest shareholder ... percent stake in the company. ValueAct Capital said: "Since our initial purchases ...
|
|